CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
Authors
A Makady
Amr Makady
+15 more
Anja Schiel
Antonella Santuccione Chadha
AT Isik
Christine Gispen-de Wied
CW Richie
D Mehta
Diana O’Rourke
Entela Xoxi
ER Siemers
J Cummings
Jacoline C. Bouvy
John Gallacher
Niklas Hedberg
Pall Jonsson
Raj Long
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 28/10/2020